Twenty-four adult participants with type 1 diabetes were randomized to use either the Simplera Sync™ or Instinct sensor for a six-week period, then crossed over to the alternate sensor for an ...

Kwame Osei, MD, one of the first researchers to document ethnic disparities in diabetes and glucose regulation, recently died ...

Cardiovascular disease (CVD) is the No. 1 killer in the United States, and the American Heart Association, a relentless force ...

US FDA accepts and grants priority review status to Bayer’s sNDA for Kerendia in chronic kidney disease associated with type 1 diabetes: Berlin Friday, May 22, 2026, 10:00 Hrs [ ...

Eli Lilly and Company , the maker of Zepbound (tirzepatide) and Foundayo (orforglipron), today announced positive topline results from TRIUMPH-1, a Phase 3 clinical trial evaluating the efficacy and ...

US Health and Human Services Secretary Robert F. Kennedy Jr. quietly removed the two top leaders of a key preventive services ...

Senate Republicans might advance the funding bill without a $1 billion provision for the Secret Service that would go toward ...

Market News Updates News Commentary - Cell-based therapies are quickly becoming one of the most talked-about areas in ...

Heart disease is the leading cause of death in the United States, and altering your diet is the most effective way to reduce the risk of heart disease, according to the American Heart Association. To ...

A new study led by researchers at the University of Massachusetts Amherst suggests that even people with a high genetic risk ...

Type 1 diabetes progresses through 3 stages: autoantibodies appear first (stage 1), then blood sugar rises without symptoms (stage 2), and finally symptoms like excessive thirst, frequent urination, ...

Mark Anderson, MD, PhD, a pioneer in diabetes research and professor of medicine at UCSF, has been elected to the National ...